Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2021
Biogen and Ginkgo Bioworks announce manufacturing partnership
Biogen and Ginkgo Bioworks announced an agreement under which Biogen will access Ginkgo’s cell-programming platform and Ginkgo will use its bioengineering capabilities to improve production of engineered viruses used in gene therapies. Biogen is paying $5 million upfront, with Ginkgo eligible for milestone payments.
2021
Ginkgo Bioworks agrees to go public through reverse merger
Ginkgo Bioworks announced an agreement with Soaring Eagle Acquisition to go public through a reverse merger. The article reports a $15 billion valuation and says the transaction would raise a total of $2.5 billion; it does not report that the deal had been completed.
2021
Helix and Ginkgo announce school COVID-19 testing partnership
Helix announced a partnership with Ginkgo Bioworks to provide pooled COVID-19 testing to K-12 schools across the western U.S.
2020
Ginkgo completes acquisition of Novogy assets
Ginkgo announced that it had recently completed an acquisition of Novogy's main assets, including strain assets and an IP portfolio, and said it would integrate Novogy's codebase and expertise into its bioengineering platform.